IMVT
Immunovant, Inc. · Healthcare
General Counsel Mark S. Levine sold $129K of Immunovant, Inc.
Sold$128,780
$29.53Price
4,361Shares
−1%Stake
What IMVT did after the filing
- The stock from Fri, Oct 25 close, $30.22
- −5.0%
- S&P 500, same days
- +4.4%
Measured over 30 trading days, to the Dec 9 close.
Traded Wed, Oct 23. Filed Fri, Oct 25, 12:25 PM ET, during the session. Returns use the Oct 25 close and the Dec 9 close. Not investment advice.